Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases

被引：0

作者：

Onal, Ugur ^{[1
,2
]}

Akyol, Deniz ^{[1
,3
]}

Kaya, Arda ^{[1
]}

Baskol, Dilsah ^{[1
]}

Kenanoglu, Buse ^{[1
]}

Sanlidag, Gamze ^{[1
]}

Onal, Ayse Uyan ^{[1
,4
]}

Avsar, Cansu Bulut ^{[1
,5
]}

Mert, Merve ^{[1
]}

Memetali, Seichan ^{[1
]}

Erdem, Hueseyin Aytac ^{[1
]}

Bozkurt, Devrim ^{[6
]}

Simsir, Adnan ^{[7
]}

Bozbiyik, Osman ^{[8
]}

Kahraman, Umit ^{[9
]}

Ozgiray, Erkin ^{[10
]}

Korkmaz, Pervin ^{[11
]}

Cilli, Feriha ^{[12
]}

Pullukcu, Husnu ^{[1
]}

Yamazhan, Tansu ^{[1
]}

Tasbakan, Meltem Isikgoz ^{[1
]}

Arda, Bilgin ^{[1
]}

Ulusoy, Sercan ^{[1
]}

Sipahi, Oguz Resat ^{[1
,13
]}

机构：

[1] Ege Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkiye

[2] Uludag Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Bursa, Turkiye

[3] Kagizman State Hosp, Infect Dis Clin, Kars, Turkiye

[4] Yuksek Ihtisas Teaching & Res Hosp, Dept Urol, Bursa, Turkiye

[5] Bakircay Univ, Cigli Teaching & Res Hosp, Izmir, Turkiye

[6] Ege Univ, Fac Med, Dept Internal Med, Izmir, Turkiye

[7] Ege Univ, Fac Med, Dept Urol, Izmir, Turkiye

[8] Ege Univ, Fac Med, Dept Gen Surg, Izmir, Turkiye

[9] Ege Univ, Fac Med, Dept Cardiovasc Surg, Izmir, Turkiye

[10] Ege Univ, Fac Med, Dept Neurosurg, Izmir, Turkiye

[11] Ege Univ, Fac Med, Dept Chest Dis, Izmir, Turkiye

[12] Ege Univ, Fac Med, Dept Med Microbiol, Izmir, Turkiye

[13] King Hamad Univ Hosp, Bahrain Oncol Ctr, Infect Dis Dept, Muharraq, Bahrain

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2023年 / 42卷 / 10期

关键词：

Double carbapenem therapy; Carbapenem-resistant Klebsiella pneumonia; Bacteremia; THERAPY; INFECTIONS;

D O I：

10.1007/s10096-023-04660-3

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Herein, we aimed to describe the outcomes of patients with blood stream infections due to carbapenem-resistant Klebsiella pneumoniae (CR-Kp) who received ertapenem plus meropenem combination treatment (EMCT). A total of 53 patients with culture proven CR-Kp bacteremia treated with ertapenem + meropenem were included. The patients with secondary bacteremia due to urinary tract infection exhibited a significantly lower 1-month mortality (OMM), particularly in those with microbiological eradication and those with end-of-treatment success. Salvage EMCT resulted in 49% 1-month survival.

引用

页码：1269 / 1273

页数：5

共 16 条

[1] Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48-and NDM-Producing Escherichia coli and Klebsiella pneumoniae
Allander, Lisa
Vickberg, Karin
Lagerback, Pernilla
Sandegren, Linus
Tangden, Thomas
[J]. ANTIBIOTICS-BASEL, 2022, 11 (11):
[2] A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting
Aslan, Abdullah Tarik
Kirbas, Ekin
Sancak, Banu
Tanriverdi, Elif Seren
Otlu, Baris
Gursoy, Nafia Canan
Yilmaz, Yakut Akyon
Tozluyurt, Abdullah
Liste, Umran
Bicakcigil, Asiye
Hazirolan, Gulsen
Dag, Osman
Guven, Gulay Sain
Akova, Murat
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (04)
[3] CDC National Healthcare Safety Network (NHSN), 2023, PAT SAF COMP MAN
[4] Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
Cprek, Jessica B.
Gallagher, Jason C.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 669 - 673
[5] Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis
Li, Yuan-yuan
Wang, Jin
Wang, Rui
Cai, Yun
[J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
[6] Moody R, 2021, J Med Res Innov, V5, DOI [10.32892/jmri.243, DOI 10.32892/JMRI.243]
[7] Noyan A, 2022, EUR C CLIN MICROBIOL
[8] Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases
Onal, Ugur
Akyol, Deniz
Mert, Merve
Baskol, Dilsah
Memetali, Seichan Chousein
Sanlidag, Gamze
Kenanoglu, Buse
Uyan-Onal, Ayse
Quliyeva, Gunel
Avsar, Cansu Bulut
Akdag, Damla
Demir, Melike
Erdem, Huseyin Aytac
Kahraman, Umit
Bozbiyik, Osman
Ozgiray, Erkin
Bozkurt, Devrim
Akarca, Funda Karbek
Demirag, Kubilay
Cankayali, Ilkin
Uyar, Mehmet
Cilli, Feriha
Arda, Bilgin
Yamazhan, Tansu
Pullukcu, Husnu
Tasbakan, Meltem Isikgoz
Sipahi, Hilal
Ulusoy, Sercan
Sipahi, Oguz Resat
[J]. JOURNAL OF CHEMOTHERAPY, 2022, 34 (07) : 436 - 445
[9] Retrospective evaluation of the patients with urinary tract infections due to carbapenemase producing Enterobacteriaceae
Onal, Ugur
Sipahil, Oguz Resat
Pullukcul, Husnu
Yamazhan, Tansu
Arda, Bilgin
Ulusoy, Sercan
Aydemir, Sohret
Tabakan, Meltem Isikgoz
[J]. JOURNAL OF CHEMOTHERAPY, 2020, 32 (01) : 15 - 20
[10] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
Paul, Mical
Carrara, Elena
Retamar, Pilar
Tangden, Thomas
Bitterman, Roni
Bonomo, Robert A.
de Waele, Jan
Daikos, George L.
Akova, Murat
Harbarth, Stephan
Pulcini, Celine
Garnacho-Montero, Jose
Seme, Katja
Tumbarello, Mario
Lindemann, Paul Christoffer
Gandra, Sumanth
Yu, Yunsong
Bassetti, Matteo
Mouton, Johan W.
Tacconelli, Evelina
Rodriguez-Bano, Jesus
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) : 521 - 547

← 1 2 →